When stratified by baseline viral load of either @,@ or > @,@ copies/mL , @/@ ( @ % ) versus @/@ ( @ % ) RPV/FTC/TDF-treated subjects and @/@ ( @ % ) versus @/@ ( @ % ) EFV/FTC/TDF-treated subjects developed resistant isolates , respectively .